The human Clara cell protein: biochemical and biological characterisation of a natural immunosuppressor

Abstract

The Clara cell protein, the human counterpart of rabbit uteroglobin, exerts an anti-inflammatory action by interfering in different ways with the cytokine-network. Firstly, CC16 behaves like an anti-cytokine by downregulating the production of IFN-γ, IL-1 and TNF-α by stimulated leukocytes. The extent of inhibition depends on the inducing agent (being maximal when IL-2 is used as inducer) and varies with the applied concentration of CC16. Secondly, the protein reduces the antiviral activity and the augmentation of phagocytosis induced by IFN-γ. In both cases (inhibition of production and biologic activity) there is a 50% reduction in the presence of 10 ng/ml CC16. The natural and IFN-γ-enduced cytotoxicity of NK-cells however, are enhanced by the presence of CC16, indicating a more complex interaction of CC16 with the immune-system. The immunosuppressive properties make CC16 a promising agent for the treatment of inflammatory reactions and auto-immune diseases.

Keywords

cytokine anti-cytokine interferon-γ phospholipase A2 Clara cell protein natural killer cells

Get full access to this article

View all access options for this article.

References

1 Lewis DB , Wilson CB . (1990) Gamma-interferon: an immunoregulatory lymphokine with immunotherapeutic potential. Pediatr Infect Dis J 9: 642–651.

2 Mantile G , Miele L , Cordella-Miele E , Singh G , Katyal SL , Mukherjee AB . (1993) Human Clara cell 10-kDa protein is the counterpart of rabbit uteroglobin. J Biol Chem 268: 20343–20351.

3 Bernard A , Roels H , Lauwerys R , Witters R , Gielens C , Soumillion A , Van Damme J , De Ley M . (1992) Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin Chim Acta 207: 239–249.

4 Bernard A , Thielemans N , Lauwerys R , Van Lierde M . (1992) Selective increase in the urinary excretion of protein 1 (Clara cell protein) and other low molecular weight proteins during normal pregnancy. Scand J Clin Lab Invest 52: 871–878.

5 Runmarker B , Andersen O . (1995) Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 118: 253–261.

6 Dierynck I , Bernard A , Roels H , De Ley M . (1995) Potent inhibition of both human interferon-γ production and biologic activity by the Clara cell protein CC16. Am J Respir Cell Mol Biol 12: 205–210.

7 Jitsukawa T , Nakajima S , Sugawara I , Mori S , De Ley M . (1987) Characterization of murine monoclonal antibodies to human interferon-gamma (IFN-γ) and their application for sandwich enzyme-linked immunosorbent assay (ELISA). Microbiol Immunol 31: 809–820.

8 Boeve C , De Ley M . (1994) Inhibition of human interferon-gamma expression by antisense oligodeoxynucleotides. J Leukoc Biol 5: 169–174.

9 Hamprecht K , Vötsch W , Anderer FA . (1986) Activation of human monocyte and natural killer cell-mediated tumour cell killing by two dialysable thymic factors. Scand J Immunol 24: 59–71.

10.

10 Korzeniewski C , Callewaert DM . (1983) An enzyme-release assay for natural cytotoxicity. J Immunol Methods 64: 313–320.

11.

11 Bonventre JV . (1992) Phospholipase A2 and signal transduction. J Am Soc Nephrol 3: 128–150.

12.

12 Mayer RJ , Marshall LA . (1993) New insights on mammalian phospholipase A2 (s); comparison of arachidonoyl-selective and-nonselective enzymes. FASEB J 7: 339–348.

13.

13 Levin SW , Butler J , Schumacher UK , Wightman PD , Mukherjee AB . (1986) Uteroglobin inhibits phospholipase A2 activity. Life Sc 38: 1813–1819.

14.

14 González KB , Nieto A . (1995) Binding of uteroglobin to microsomes and plasmatic membranes. FEBS Lett 361: 255–258.